The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

23 May 2018 16:16

RNS Number : 0841P
Medica Group PLC
23 May 2018
 

 

23 May 2018

Medica Group Plc

 

Result of Annual General Meeting

 

Medica Group Plc (LSE: MGP, "Medica" or the "Company") announces that, at its Annual General Meeting held at the offices of Eversheds Sutherlands (International) LLP at One Wood Street, London at 10.00 a.m. today, all resolutions put to the meeting were duly passed.

 

Resolutions

For (including discretionary votes)

% of votes

Against

% of votes cast

Votes cast as a % of relevant shares in issue

Ordinary business

1

To receive and adopt the annual report and accounts of the Company and its subsidiaries for the year ended 31 December 2017

90,012,191

99.61

355,452

0.39

81.33

2

To re-appoint Grant Thornton UK LLP as auditors to the Company

90,077,229

99.68

290,413

0.32

81.33

3

To authorise the Directors to determine the remuneration of the auditors of the Company

90,366,342

99.99

1,301

0.01

81.33

4

To declare a final dividend for the year ended 31 December 2017 of 1.1p per ordinary share

90,367,643

100

-

-

81.33

5

To approve the Directors' Remuneration Report (other than the part containing the Directors' Remuneration Policy) for the year ended 31 December 2017

48,860,702

54.07

41,498,640

45.93

81.32

5A

To approve the Directors' Remuneration Policy in the form set out in the Directors' Remuneration Report

89,681,853

99.25

677,489

0.75

81.32

Special business

6

General authority to allot shares pursuant to Section 551 Companies Act 2006

90,094,299

99.99

8,398

0.01

81.09

7*

Disapplication of pre-emption rights (5% general authority)

79,380,605

87.84

10,987,038

12.16

81.33

8*

Disapplication of pre-emption rights (5% additional authority for an acquisition or specified capital investment)

79,103,170

87.53

11,264,472

12.47

81.33

9*

Authority for on-market purchases of up to 10% of issued share capital

90,089,208

99.69

278,434

0.31

81.33

10*

Authority to call general meetings at 14 clear days' notice

90,201,804

99.82

165,839

0.18

81.33

11

Approve the rules of the Medica Group PLC Company Share Option Plan 2018

89,683,891

99.25

675,451

0.75

81.32

 

* Passed as a special resolution of the Company; all other resolutions were passed as ordinary resolutions of the Company.

 

N.B. Percentage of Votes cast excludes withheld votes. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes validly cast.

 

The Board is pleased to have received shareholder support for all the resolutions proposed at the AGM. The Remuneration Policy was passed with 99% votes in favour. However, the Company recognises the lower level of support it has received for the advisory vote on its Directors' Remuneration Report.

 

The Company's Remuneration Committee, which is keen to foster an open and transparent approach to remuneration, spent a significant amount of time during the period (including before the IPO) in finalising executive remuneration arrangements to ensure these were appropriate for Medica and reflected best practice.

 

The Remuneration Committee understands that the votes against are attributable, in large part, to concerns regarding the level of disclosure in relation to the LTIP targets. Medica is committed to providing a level of disclosure that is acceptable to shareholders. The Board have reflected on the comments received from shareholders and whilst it was always the intention to publish the targets at the conclusion of the performance period, we now expect to bring this forward and publish the targets for the previous year in the relevant Annual Report. This will commence from next year's report which will include the performance criteria for the 2017 and 2018 award.

 

The number of Ordinary Shares in issue on 23 May 2018 at 10.00 a.m. was 111,111,114. Shareholders are entitled to one vote per share.

 

The full text of the resolutions can be found in the Notice of AGM on the Company's website (www.medicagroup.co.uk).

 

A copy of this announcement will shortly be available for inspection at the National Storage Mechanism document viewing facility at www.morningstar.co.uk/uk/NSM.

 

Enquiries:

 

Medica Group:

+44 (0)33 33 111 222

John Graham, Chief Executive Officer

Tony Lee, Chief Financial Officer

Investec Bank plc

+44 (0)20 7597 5970

Sara Hale

Daniel Adams

Henry Reast

Edward Thomas

David Herring

FTI Consulting

+44 (0)20 3727 1000

Brett Pollard

Ben Atwell

Victoria Foster Mitchell

Robert Winder

 

About Medica

 

Medica is the UK market leader by revenue in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional (Routine CS) reporting on MRI and CT scans, and routine plain film (Routine PF) reporting on x-ray images.

 

Medica has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.5 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 

 

About teleradiology

 

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGEASSDAFLPEFF
Date   Source Headline
23rd Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 20194:38 pmRNSChange of Registered Address
7th Jun 201912:02 pmRNSPrice Monitoring Extension
31st May 201912:06 pmRNSNotification of Major Holdings
29th May 201910:13 amRNSNotification of Major Holdings
22nd May 20193:15 pmRNSResult of AGM
22nd May 20197:00 amRNSAnnual General Meeting Statement
9th May 20197:00 amRNSDr Stuart Quin appointed Chief Executive Officer
7th May 20199:33 amRNSNotification of Major Holdings
3rd May 20191:30 pmRNSDirector/PDMR Shareholding
26th Apr 20197:01 amRNSDirector/PDMR Shareholding
26th Apr 20197:01 amRNSDirector/PDMR Shareholding
26th Apr 20197:00 amRNSPosting of Annual Report, Accounts, Notice of AGM
25th Apr 20191:36 pmRNSNotification of Major Holdings
25th Apr 20197:00 amRNSJo Easton Appointed Non-Executive Director
5th Apr 201911:58 amRNSHolding(s) in Company
3rd Apr 20194:40 pmRNSSecond Price Monitoring Extn
3rd Apr 20194:35 pmRNSPrice Monitoring Extension
25th Mar 20197:00 amRNSFinal Preliminary Results
26th Feb 20199:41 amRNSHolding(s) in Company
24th Jan 20197:00 amRNSPost-Close Trading Update
22nd Jan 201911:39 amRNSNotification of Major Holdings
22nd Jan 201911:38 amRNSNotification of Major Holdings
11th Jan 20194:35 pmRNSPrice Monitoring Extension
20th Dec 20187:00 amRNSNon-executive Director Change
4th Dec 20187:02 amRNSPrice Monitoring Extension
3rd Dec 20184:35 pmRNSPrice Monitoring Extension
25th Sep 20189:15 amRNSNotification of Major Holdings
21st Sep 20185:43 pmRNSDirector/PDMR Shareholding
19th Sep 20184:35 pmRNSPrice Monitoring Extension
12th Sep 20187:00 amRNSUnaudited half year results
23rd Aug 20184:35 pmRNSPrice Monitoring Extension
3rd Aug 201811:17 amRNSNotification of Major Holdings
27th Jul 20184:45 pmRNSNotification of Major Holdings
25th Jul 20187:00 amRNSPre-Close Trading Update
12th Jul 20184:13 pmRNSNotification of Major Holdings
3rd Jul 20189:00 amRNSNotice of Interim Results
2nd Jul 20184:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20184:35 pmRNSPrice Monitoring Extension
26th Jun 201812:49 pmRNSNotification of Major Holdings
25th Jun 20183:49 pmRNSNotification of Major Holdings
12th Jun 20184:40 pmRNSSecond Price Monitoring Extn
12th Jun 20184:35 pmRNSPrice Monitoring Extension
23rd May 20184:16 pmRNSResult of AGM
23rd May 20187:00 amRNSAnnual General Meeting Statement
21st May 201810:03 amRNSNotification of Major Holdings
17th May 20189:56 amRNSHolding(s) in Company
16th May 201810:45 amRNSHolding(s) in Company
27th Apr 201811:30 amRNSAmendments to Notice of Annual General Meeting
25th Apr 20184:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.